Navigation Links
LeMaitre Vascular Acquires Biomateriali, a Vascular Graft Manufacturer
Date:12/20/2007

BURLINGTON, Mass., Dec. 21 /PRNewswire-FirstCall/ -- LeMaitre Vascular, Inc. (Nasdaq: LMAT), a provider of peripheral vascular devices and implants, yesterday acquired Biomateriali S.r.l., a privately held Italian vascular graft manufacturer, for euro 1.8 million in cash, the assumption of euro 0.8 million in intercompany liabilities, and contingent liabilities of euro 1.0 - euro 1.5 million. The acquisition was structured as a stock purchase.

Key attributes of Biomateriali:

-- Biomateriali designs, manufactures, and markets straight and bifurcated

polyester arterial prostheses. Polyester vascular grafts are used in a

variety of arterial replacement and repair surgeries, predominantly

open abdominal aortic aneurysm ("AAA") repair. Biomateriali has been

manufacturing these prostheses under the "Albograft" brand for over 10

years.

-- Biomateriali's net revenues were approximately euro 2.1 million in the

last twelve months. Depending upon the amount of contingent liabilities

eventually paid, the acquisition was executed at a 1.7x - 2.0x multiple

of LTM revenues.

-- Biomateriali's Albograft implants are CE-marked and distributed

exclusively by Edwards Lifesciences throughout Europe and in select

international markets. Biomateriali also supplies straight polyester

conduit grafts for cardiovascular surgery on an OEM basis to the Sorin

Group.

-- Biomateriali has 30 employees in a 15,000 square foot manufacturing

facility in Brindisi, Italy.

"The polyester vascular graft market continues to represent one of the larger markets in vascular surgery," said David B. Roberts, President of L
'/>"/>

SOURCE LeMaitre Vascular, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. LeMaitre Vascular Appoints Russell D. Hays to Its Board of Directors
2. Boston Scientific to Explore Sale of Cardiac Surgery and Vascular Surgery Businesses
3. AGA Medical Corporation Receives FDA and CE Mark Approvals for the AMPLATZER Vascular Plug II
4. Legendary Earvin Magic Johnson Joins AFL/Signalife Cardiovascular Protection Team
5. Edwards Lifesciences Grants UC Irvine $5 Million to Establish the Edwards Lifesciences Center for Advanced Cardiovascular Technology
6. Micrus Endovascular to Webcast Fiscal 2007 Annual Meeting of Stockholders
7. Cardica and Cook Sign Agreement to Expand Cook Vascular Closure Device Product Family
8. NFL Hall of Fame Legend Fred Biletnikoff Joins AFL/Signalife Cardiovascular Protection Team
9. FDA Clears OmniWave(TM) Endovascular System for Clot Removal in Peripheral Blood Vessels
10. Amarin Announces Initiation of Cardiovascular Development Strategy
11. VIA Pharmaceuticals Lead Compound, VIA-2291, Chosen as a Top Ten Most Licensable Cardiovascular Program for Windhover Informations Therapeutic Area Partnerships Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/10/2014)... 2014 Product and process impurities ... abundance and are often “lost in the noise,” ... Join presenters Dr. Rowel Tobias, Senior Scientist, Protein ... Head of Quality at Nanotherapeutics, Inc., to lear ... speed detection and quantitation while achieving the required ...
(Date:7/10/2014)... 10, 2014 Terascala, the industry leader ... Alan Swahn, a former vice president of product management ... vice president of marketing. Terascala’s software when combined with ... create the highest performance and most reliable solutions for ... guide Terascala’s channel expansion and broaden its product portfolio. ...
(Date:7/10/2014)... CA (PRWEB) July 10, 2014 OMICS ... Bioanalytical techniques during 18-20 August, 2014 at Double Tree ... review the recent developments in Analytical & Bioanalytical research ... globe. , Speaking on this occasion, Dr. Srinubabu Gedela, ... Analytica Acta conference is a remarkable one in bringing ...
(Date:7/10/2014)... , July 10, 2014  Franciscan St. ... of capnography for respiratory monitoring outside the ... healthcare leaders in embracing state-of-the-art patient safety ... patients are breathing and can alert medical ... measuring the amount of carbon dioxide the ...
Breaking Biology Technology:Novel Ms Techniques Speed Detection of Biopharmaceutical Product and Process Impurities, New Webinar Hosted by Xtalks 2Terascala Expands Executive Team 2Terascala Expands Executive Team 3A Critical Review of Analytical Techniques for Improved Living Standards 2A Critical Review of Analytical Techniques for Improved Living Standards 3A Critical Review of Analytical Techniques for Improved Living Standards 4Franciscan St. Anthony Health-Crown Point Underscores Patient Safety Commitment Through Expanded Use of Capnography 2
... 20, 2011 Onyx Pharmaceuticals, Inc. (Nasdaq: ONXX ... teleconference with management to discuss third quarter 2011 financial results, ... November 2, 2011, at 5:00 p.m. Eastern Time (2:00 p.m. ... 30, 2011 will be released earlier that day. ...
... Dyadic International, Inc. (OTC Pink: DYAI), a ... report its financial results for the third quarter ... conference call to discuss those financial results as ... Results Release:  After market close, Thursday, November 3, ...
... Therapeutics Corporation (NASDAQ: UTHR ) announced today ... results before market open on Thursday, October 27, 2011. ... on Thursday, October 27, 2011, at 9:00 a.m. Eastern ... international callers dialing 1-970-315-0533.  A rebroadcast of the teleconference ...
Cached Biology Technology:
(Date:7/11/2014)... for Bone and Mineral Research awarded Michael F. Holick, ... with the 2014 Louis V. Avioli Award. Holick, a ... internationally known for revolutionizing the understanding of vitamin D ... award honors a member of the American Society for ... bone and mineral basic research. It is named for ...
(Date:7/11/2014)... release is available in German . ... a method that uses the refraction of X-rays through ... images produced with this method are often of much ... in the team of Prof. Franz Pfeiffer are particularly ... and therapy including X-ray phase-contrast imaging. One main ...
(Date:7/11/2014)... at the National Institute of Standards and Technology ... work more effectively, they often prove that necessity ... the case recently for M. Lorna De Leoz ... growing specialization of glycomics. Glycomics is the study ... that are attached to proteins and lipids and ...
Breaking Biology News(10 mins):BUSM's Michael F. Holick receives American Society for Bone and Mineral Research award 2New simple setup for X-ray phase contrast 2
... After the completion of a draft sequence of the Chinese ... in 2002, CAS researchers have recently finished the fine map ... recent issue of PLoS Biology (Vol.3 Issue 2, 2005), scientists ... "much improved, near-complete genome analysis of the indica and japonica ...
... provoke allergic reactions? A new study in the February ... some of the blame on bioactive molecules that are ... and cause them to launch a typical allergy-promoting immune ... more of these allergy-provoking compounds than do pollen from ...
... widely-used class of drugs that keep the HIV-virus infection ... lethal heart rhythm disturbances in some patients. The finding ... edition of The Lancet. , In collaboration with ... Center, Minneapolis; the University of Minnesota, Minneapolis, and University ...
Cached Biology News:Whole genome fine map of rice completed 2HIV Patients May Be at Risk of Heart Problems When Taking Protease Inhibitor Drugs 2HIV Patients May Be at Risk of Heart Problems When Taking Protease Inhibitor Drugs 3
Lipid-rich bovine serum albumin for cell culture. It is chromatographically purified and has an IgG content 1.0% (w/w)....
Penicillin-Streptomycin liquid...
...
This SMAD antibody sampler pack contains 5 Polyclonal ,SMAD antibodies....
Biology Products: